|
Listen to incredible audio testimonials (10 minutes)
Ronnie Coleman 7x
Mr. Olympia (pictured above) - "There's a reason why I
use LifeWave. IT WORKS."
|
A BRIEF INTRODUCTION TO THE LIFEWAVE TECHNOLOGY AND
EXPLANATION OF THE PHENOMENA ASSOCIATED WITH ITS USE By David Schmidt, President, LifeWave Products, LLC
OVERVIEW
- LifeWave is a new technology that consists of orthomolecular organic
structures that passively interact with the human body for the purpose of
inducing electron flow and thermomagnetic frequency modulation.
- The induced electron flow assists in recruiting calcium ions into the
muscle fiber during the contraction phase, allowing the user to utilize more
muscle fiber during contraction, thereby allowing the LifeWave user to lift
heavier weights.
- The passive thermomagnetic frequency modulation of the LifeWave technology
creates a condition in which the transport of long chain fatty acids across
the Mitochondrial membrane for subsequant beta-oxidation and energy production
is increased, providing the LifeWave user with increased energy and stamina.
- In third party tests conducted independently, over 99% of LifeWave users
experienced significant improvements in physical strength after a few minutes
of using LifeWave, with typical increases being 10% and higher.
- In third party tests conducted independently, over 99% of LifeWave users
experienced significant increases in stamina after a few minutes of using
LifeWave, with typical increases being 25% and higher.
- All materials in LifeWave have been clinically tested for safety and
efficacy, and are listed under FDA 21 CFR.
- All LifeWave devices are manufactured at FDA registered facilities.
- Patent Pending
INTRODUCTION
The LifeWave
technology is a new, Patent Pending and innovative approach to performance
enhancement, to increase stamina and energy. The LifeWave device is presently
embodied in the form of a sport patch, and as such is worn by a user at specific
points on the human body in the same fashion as a band aid or transdermal patch.
The LifeWave products contain NO magnets, NO batteries, NO copper or dissimilar
metals, it is NOT a transdermal infusion system or anything of this nature.
Instead, LifeWave utilizes in part a novel arrangement and proprietary
process-construction of FDA listed beneficial orthomolecular organic compounds
to achieve the truly amazing results reported to LifeWave by users of the
products. These orthomolecular organic compounds have been determined by the FDA
to be safe for use in the presence of humans; in addition, the materials
utilized in the ground-breaking research conducted by LifeWave scientists are
more fully described as complex orthomolecular organic structures that are
capable of either thermomagnetic levorotatory action due to the atom proton
energy associated with thermomagnetic fields or thermomagnetic dextrorotatory
action due to the atom proton energy associated with thermomagnetic fields. In
both cases, in the practical embodiments of the LifeWave devices, the
orthomolecular organic materials utilized are arranged parallel with respect to
the plane of thermomagnetic rotation. LifeWave Products, LLC manufactures the
LifeWave Sport Patch devices at FDA registered facilities that comply with GMP
and QSR requirements.
PRINCIPLE - THEORY OF OPERATION
How does the
LifeWave technology work? The LifeWave concept is based on the principle that
the atom proton energy associated with human thermomagnetic fields are capable
of interacting with passive orthomolecular organic materials so long as these
materials are arranged parallel to the plane of rotation, with this arrangement
inducing electron flow due to well known and long established electromotive
principles. It is well known in conventional industrial electrical generators
and alternators that electricity is produced as a result of the relative
rotation of magnetic fields in the presence of a conductor such as copper wire.
In the LifeWave technology and device, the human body provides both the
oscillating thermomagnetic field as well as the conductive media (electrolytes),
with the LifeWave device passively interacting with this thermomagnetic field so
as to induce electron flow in the conductive media through field shaping and
resonance feedback effects.
Recently, work performed in the field of
thermally induced quantum tunneling effects have yielded devices capable of
thermionic emission at a scale of only 20 nanometers. In these devices, electron
or ion emission are due to the temperature of the emitter, with the rate of
emission increasing rapidly with a resultant increase in temperature. These
devices in part mimic conditions existing at the microscopic level in human
beings. In addition, work performed by Brownridge has demonstrated in the
laboratory that either thermal gradients or static thermal conditions are
capable of inducing potential gradients in certain crystalline organic materials
where the enharmonic ionic vibrations of these materials lack a center of
symmetry and as a result produce crystalline polarization. Again, these systems
for producing electron flow and potential are present at the microscopic level
in human beings.
It is well known that hemoglobin is the Iron-containing
pigment of the red blood cells. Its function is to carry Oxygen from the lungs
to the tissues. It is also well known that collagen is a Copper containing,
fibrous insoluble protein in the connective tissue, including skin, bone,
ligaments and cartilage. In addition, human beings possess a natural temperature
differential from the core to the extremities.
In physics, the Seebeck
effect describes a phenomena in which when a system consists of two metals (such
as Iron and Copper), with one metal at a higher temperature than the other, a
current flows in the system. The Thomson thermoelectric effect is the
designation of the potential gradient along a conductor which accompanies a
temperature gradient. The thermomagnetic phenomena arises in that the
thermoelectric and thermomagnetic power is measured by the electromotive force
produced by the unit difference of temperature, in this case the temperature
differential from the core to the extremities. In short, all of the conditions
necessary for human beings to produce thermomagnetic fields and electron flow
are present in humans.
The LifeWave technology is a passive device,
constructed in a new and proprietary process-construction of safe and beneficial
orthomolecular organic compounds for the purpose of improving human performance
through the interaction of the device with the human thermomagnetic field, with
it being believed by LifeWave that said interaction of the LifeWave device with
the individual induces an electron flow in the individual. This interaction is
not unlike the effect that occurs in an electrical generator in which
electricity is produced from moving magnets or magnetic fields. In humans, the
increase in electron flow has numerous demonstrable benefits such as an
immediate and measurable increase in physical strength, improved stamina and
pain relief.
MAGNETIC AND THERMOMAGNETIC
FIELDS
Thermomagnetic fields arise as a result of dissimilar
materials forming junctions along a temperature gradient. The thermoelectric
effect has been known for well over 150 years, and was first discovered by
Michael Faraday. In humans, Iron containing hemoglobin forms microscopic and
macroscopic junctions with copper containing collagen, with these junctions
occurring along a temperature gradient that initiates at the core with a
corresponding temperature drop at the extremities.
Traditional magnetic
fields (H) are defined as the region surrounding a moving charge, such as when
electrons move through a conductor. These conditions also exist within humans,
however the focus of this discussion pertains to thermomagnetics. Furthermore,
materials such as Iron that are capable of being magnetized permanently are
defined as being ferromagnetic (results from parallel alignment of neighboring
magnetic dipoles) and materials such as Copper are defined as being diamagnetic
(nonpermanent magnetism where the magnetic susceptibility is negative;
diamagnetism is expressed vividly in superconductivity). Thermomagnetic fields,
however, are distinguished from both ferromagnetic phenomena and diamagnetic
behavior in that the thermomagnetic field produced is not the result of
alignment of magnetic dipoles but rather the result of a thermally induced
condition of electron charges moving through a conductor.
As a case in
point, if we were to take a bar of Copper and maintain a temperature gradient
from one end to the other, if the hot side was high enough a thermal increase in
kinetic energy of the outer orbit electrons would occur and allow the electrons
to discharge into space. In practice, due to the electrical conductivity of
Copper, the electrons shift in tremendous quantity to the cool side of the
Copper bar with the heat propagation velocity. Excited electrons on the cool
side will now travel toward the hot side encircling the Copper bar by gyroscopic
phenomena. The result is low voltage (millivolts) at high current.
In
experiments performed that were designed to produce very large thermomagnetic
fields (10000 Gauss), conditions have been achieved in which the EMF of a ring
containing Iron and Copper junctions (at a thermal gradient) traveled in linear
velocity equal to the heat propagation, with the resulting kinetic energy in the
orbital electron spinning being so great that electron shells travel on the same
orbital plane. As a result, portions of the atom proton energy are exposed to
the center of the ring. It is quite obvious that this thermomagnetic phenomena
is unique and easily distinguishable from traditional ferromagnetic and
diamagenetic behavior.
THERMOMAGNETIC DEVICES
Schroeder
has performed work in artificially produced thermomagnetic fields which have
found practical application in the direct conversion of waste heat to magnetism.
In these devices, a low voltage generating unit is formed by alternate segments
of dissimilar metals arranged in the form of helix formed into a loop or torus,
with heating and cooling of alternate junctions causing a low voltage but high
current flow, current flow being dependent upon temperature differential between
alternate junctions, junction area, and size of the unit. The voltage generated
by heating and cooling junctions of dissimilar metals is less than one volt but
with properly shaped dissimilar metal segments arranged in a torus fashion with
alternate junctions heated and cooled there is a large current flow.
In
humans, the properties of the thermomagnetic field are similar to those
replicated in the device as sited above, namely low voltage and high current
power conditions. This is consistent with the physiological parameters of human
microbiology in that the cell potential is between 45mV and 70mV. As such, any
thermomagnetic field produced by a human being, and hence any induced electron
flow that would result from this field, would be completely compatible with the
existing cell potential found in humans.
STRENGTH - THEORY OF
OPERATION
Users of the LifeWave device and technology have
experienced immediate and demonstrable increases in physical strength within
minutes after wearing the LifeWave device. This is not a chemically induced
increase in strength such as would be the case with anabolic steroids, etc. but
rather a phenomena in which existing muscle mass is utilized more efficiently
due to the increase in electron flow. To understand how this phenomena could be
possible, if we examine the striated skeletal muscle system we know that this
voluntary group nerve supply is under conscious control because these nerves are
branches of the peripheral cerebrospinal nervous system (the brain and spinal
cord as the cerebrospinal axis). The muscle fibers themselves are tissues
composed of contractile cells that effect movement based on the excitatory
process set up in nerve fibers by stimuli (the nerve impulse). It is presently
believed by medical research that the nerve impulse is probably in the nature of
a wave of electrochemical disturbances. The efficiency with which large muscle
groups are contracted can be defined as the number of muscle fibers utilized in
a contraction divided by the number of fibers present in that muscle group. It
is presently believed that most humans only contract a small percentage of
muscle fibers in a given group for a given nerve impulse (low efficiency of
muscle mass usage as a function of number of muscle fibers contracted divided by
number of muscle fibers present; not all motor units respond to a given
stimulus).
If now we were to induce a condition in which the total power
available for nerve impulses could be increased so that more muscle fibers could
contract for a given muscle group, the net efficiency of the striated fibers
would increase (more muscle fibers in a group being contracted in a contraction
phase; more motor units responding to a stimulus), and hence usable physical
strength could be improved. It is believed by LifeWave Products, LLC that this
is one possible explanation for the phenomena associated with users of the
LifeWave technology, namely immediate and demonstrable increases in strength and
stamina within minutes of wearing the LifeWave technology.
In support of
this explanation, work performed by Mower in the augmentation of muscle
contractility by biphasic stimulation lends validity to this argument. In this
work, Mower sites that enhanced myocardial function is obtained through biphasic
pacing. The combination of cathodal with anodal pulses of either a stimulating
or conditioning nature, preserves the improved conduction and contractility of
anodal pacing while eliminating the drawback of increased stimulation threshold.
The result is a depolarization wave of increased propagation speed. This
increased propagation speed results in superior cardiac contraction leading to
an improvement in blood flow.
Striated muscle may also be stimulated
electrically, chemically, mechanically or by temperature change. Where the
muscle fiber is stimulated by a motor neuron, the neuron transmits an impulse
that activates all of the muscle fibers within its control, that is, those
muscle fibers in its motor unit. Depolarization in one region of the membrane
stimulates adjacent regions to depolarize as well, resulting in a wave of
depolarization traveling over the membrane in all directions away from the site
of stimulation. Thus, when a motor neuron transmits an impulse, all the muscle
fibers in its motor unit are stimulated to contract simultaneously.
The
minimum strength to elicit a contraction is called the threshold stimulus. Once
this level of stimulation has been met, the generally held belief is that
increasing the level will not increase the contraction. Additionally, since the
muscle fibers within each muscle are organized into motor units, and each motor
unit is controlled by a single motor neuron, all of the muscle fibers in a motor
unit are stimulated at the same time. However, the whole muscle is controlled by
many different motor units that respond to different stimulation thresholds.
Thus, when a given stimulus is applied to a muscle, some motor units may respond
while others may not.
Therefore, artificial means of externally applied
cathodal and anodal pulses of his biphasic stimulation provides improved and
enhanced contraction of striated muscle.
Similarly, striated muscle
stimulation can also serve to preserve the neural pathway, such that, upon
healing of the nerve fibers associated with the stimulated tissue, patients
"remember" how to contract that particular muscle.
In short, for a given
stimulus applied to a striated muscle group, not all motor units will respond to
that stimulus, hence not all muscle fibers in that group will contract for a
given stimulus in that contraction phase. Externally applied biphasic
stimulation has demonstrated the capability of augmentation of the contraction
phase for enhanced or improved contractility. In the LifeWave device, the
induced electron flow is created from an external passive device in a new and
novel way, with the end result being an improvement in the contraction phase for
a given muscle group as a result of more motor units being capable of responding
to a given stimulus.
For additional supportive documentation, studies
performed and published in the Journal Of Cardiovascular Electrophysiology (as
one example) reinforce the above as stated.
In addition to the above, it
has been well known since the 1970's (Becker) that maintaining a localized
potential in the human body will have the ability to draw calcium ions to the
site. This method has been successfully utilized by Becker to improve the rate
at which broken bones heal.
In the LifeWave device, an induced electron
flow could have the same effect in drawing calcium ions into muscle fibers for
the purpose of improving the efficiency of muscle mass usage.
It is well
known that striated muscle is activated by motor nerves under voluntary control
and is concerned with locomotion. It is composed of large, long fibers that
consist of multinucleate cells. Within each fiber are longitudinal Myofibrils,
each with a distinctive pattern of bands caused by the distribution of the
proteins Actin and Myosin. The bands for repeating units are called sarcomeres.
Myofibril banding patterns during contraction and relaxation phases are easily
distinguishable. The contraction of voluntary muscle is best understood by the
"sliding filament" theory. First, the muscle needs stimulation by an impulse
from a motor nerve. Second, the actin and myosin filaments make contact to form
a complex called Actomyosin. This complex can only be formed in the presence of
calcium ions. Since the muscle fibers are organized into motor units, and each
motor unit is controlled by a single motor neuron, all muscle fibers in a motor
unit are stimulated at the same time. However, the whole muscle group is
controlled by many different motor units that respond to different thresholds.
Therefore, for a given muscle contraction, not all muscle fibers contract during
the contraction phase (low efficiency of muscle mass usage).
The LifeWave
technology is a passive device composed of orthomolecular organic structures
arranged parallel to the plane of human thermomagnetic rotation. The LifeWave
device initiates an induced flow of electrons within the user, much in the same
way that a generator produces electricity. This action improves the efficiency
of muscle contraction by recruiting more calcium ions through attraction (allows
for formation of actomyosin) and improves the efficiency of muscle mass usage
(more muscle fibers in a group contract during the contraction phase). The end
result is that within minutes of wearing the LifeWave device, the user becomes
physically stronger.
STAMINA - THEORY OF OPERATION
Users of the
LifeWave device and technology have experienced immediate and demonstrable
increases in physical stamina within minutes after wearing the LifeWave device.
Actual results obtained from users have been as low as 8% improvements to as
high as 400% improvements. The passive thermomagnetic frequency modulation of
the LifeWave technology creates a condition in which the transport of long chain
fatty acids across the mitochondrial membrane for subsequent beta-oxidation and
energy production is triggered or improved, thereby providing the user with
increased energy and stamina.
To understand how this phenomena could be
possible, let us examine the metabolic process involving primary energy sources
within the human body. For the purpose of this discussion, we shall focus on
fatty acids, a hydrocarbon in which one of the hydrogen atoms has been replaced
by a carboxyl group, also described as a monobasic aliphatic acid made up of an
alkyl radical attached to a carboxyl group.
Essential fatty acids - those
that have been determined to be essential to maintain health and can not be
synthesized by the human body - are by example the unsaturated fatty acids such
as linoleic, linolenic and arachidonic.
The metabolic role of fatty acids
may be described in part in that fatty acids are one of the primary sources of
energy for humans, and through Beta-Oxidation, are broken down into basic units
of energy. Of interest here is that in order for this process to work, fatty
acids need to enter the mitochondria for Beta-Oxidation, and they are unable to
penetrate the inner mitochondrial membrane by themselves.
In addition to
lipid metabolism, the mitochondria is involved with protein synthesis, and by
using either phase-contrast microscopy or electron microscopy, the mitochondrial
filaments or rods are seen to be 0.5 micrometers in diameter. This information
is significant in that in the LifeWave technology, materials and structures must
be selected based upon the resonant and sympathetic frequencies of the
mitochondria during both protein synthesis and lipid metabolism, while not
interfering with the other primary objective of the technology, namely assisting
in the recruitment of calcium ions to muscle fiber sites (for formation of
actomyosin).
In the human body, to overcome the problem of the inability
of fatty acids to transport from the cytosol (soluble portion of the cell)
across the mitochondrial membrane, it has been determined by several researchers
that various nutrients are essential to transport long chain fatty acids from
the cytosol across the mitochondrial membrane for fatty acid
oxidation/metabolism and energy production.
However, other methods -
other than the use of nutrients - of assisting the fatty acids across the
mitochondrial membrane are possible. In experiments performed by the author, a
method was discovered that involved an active energy source that is capable of
both improving or increasing cell motility and cell metabolic rate. In this
method, a function generator was utilized as a waveform source and
multi-frequency input to a radio transmission unit. The radio transmitter was
used to produce a high frequency carrier wave, while the function generator
provided the "primary" frequencies of study. A linear amplifier was used to
increase the transmitters output to about 300 watts, and the "antenna" in this
system, which is used for transmitting the signal, is a high impedance
plasma-producing receptacle.
In operation, an in vitro analysis was
performed in which various modulation frequencies were studied for there effects
on cell motility and mitochondrial metabolic rate. In summary, it was discovered
that by using this equipment in vitro, both cell motility and mitochondrial
metabolic rate could be actively altered (either decreased or increased) with
specific modulation frequencies (frequencies dependent upon type of cell being
investigated, material being metabolized, etc.)
To obtain the desirable
effect of improving cell metabolism passively (specifically, increasing the rate
of fatty acid Beta-Oxidation by allowing fatty acids to transport across the
mitochondrial membrane) the author constructed a LifeWave device consisting of
orthomolecular organic structures designed to passively interact with the human
thermomagnetic field for the purpose of creating a system of thermomagnetic
frequency modulation.
In the experiment described above, the desired
effect (increased cell metabolic rate) was accomplished actively by coupling the
desired frequency to a high energy plasma source. In the LifeWave device, the
desired frequency is obtained passively through material selection, material
arrangement and material processing, with the device coupling to the human body
by passive modulation of the human thermomagnetic field. The end result is that
what has been observed by LifeWave users is dramatic improvements in stamina and
energy levels within minutes of product use.
As an example, in tests
performed, users were asked to perform an exercise such as push-ups, Bench
Press, Curl, etc. for 1 set and perform as many repetitions as possible. In all
cases users were able to perform more repetitions when using LifeWave than
without. A representative example would be one user who performed a Barbell Curl
with 100 lbs. for 3 repetitions without LifeWave; the LifeWave patches were
applied and worn for 1 minute, and then the user was able to perform 9
repetitions with the same 100 lbs.
RESULTS OBTAINED
A group of over 50 individuals
was selected from a broad cross section of the general population. Each
individual volunteered to participate in a series of tests designed for the
purpose of collecting initial preliminary data of the effectiveness of the
LifeWave technology. (These tests are separate from independent lab tests). Some
of the information desired from these tests included change in strength, change
in stamina and pain relief. As an initial indicator, a simple strength
resistance test was administered to each individual by way of conventional
physical therapy protocols eg. adduction of either arm. In every case, every
individual demonstrated an improvement in strength while wearing the LifeWave
device.
In more quantitative studies, users were asked to perform tests
using both hand dynamometers and free weights. As representative examples, one
individual produced a nominal hand pressure of 140 lbs. in the control test,
followed by 160 lbs. of hand pressure while wearing the LifeWave device. A
representative example with free weights would be an individual who under
control conditions achieved a bench press of 385 lbs., but after wearing the
LifeWave device lifted 415 lbs.
With respect to stamina improvements,
gains of 25% and better were achieved by individuals while wearing the LifeWave
device as compared with the control. As a representative example, an individual
who could bench press 200 lbs. for 8 repetitions without the LifeWave device
could now bench press the same weight 12 to 16 repetitions while wearing the
LifeWave device.
There have also been dozens of reported cases of pain
abatement while individuals have worn the LifeWave device. Examples would
include relief from muscular aches, back aches, head aches, tendinitis, and many
others.
The phenomena as observed is not unusual or unknown in other
devices; the way in which the LifeWave device has achieved these results is new
and innovative. For example, in physical therapy electrical signals are utilized
for the purpose of forcing voluntary muscle groups to contract under
stimulation. These devices are commonly known as electrical or electronic muscle
stimulators (EMS) and cause stimulated contraction and relaxation phases of
muscle groups. In the LifeWave device, based on the mode of operation as
presented, an improvement in net efficiency of total muscle mass utilized during
a contraction phase may be achieved due to an increase in electron flow during
the wave of electrochemical disturbances created by the nerve impulse (more
motor units responding during a contraction phase).
In studies that have
been conducted with volunteers from a broad cross section of the general
population, in each and every case users experienced an immediate increase in
physical strength directly attributed to the LifeWave device. In other studies
conducted, users of the LifeWave technology have reported relief from a variety
of pain due to muscular aches, headaches and the like. In all cases, the pain
relief occurred in a range of from 2 minutes to 30 minutes.
A REAL WORLD STUDY
The following
third party independent study was performed by Joseph A. Goodson MS, ATC, Head
Athletic Trainer at Morehouse College in Atlanta, GA. A summary of the test and
results follows.
A group of 40 athletes were randomly selected to
participate in a LifeWave test study. Athletes were divided into groups as
follows: GROUP (1) consisted of 10 track and field athletes, and served as a
control group; GROUP (2) consisted of 10 track and field athletes, and served as
a test group for the LifeWave patches; GROUP (3) consisted of 10 football
athletes, and served as a control group; GROUP (4) consisted of 10 football
athletes, and served as a test group for the LifeWave patches.
All
athletes in all groups were first required to participate in a base line study,
with said study to be used as a reference for comparison. The base line data was
collected during the first week of the study for all athletes. The control and
test studies were performed the following week for all groups.
For the
track and field athletes, the tests performed consisted of 90 minute sprint
sessions. Each athlete was monitored for any potential adverse reaction such as
abnormal change in heart rate, etc. during these tests. At the end of the tests,
the athletes were asked to complete a questionnaire, and report - subjectively -
how they felt during the sprint session and after the sprint session.
Information of interest included how well the athlete was able to recover
between sprints, any muscle cramping during or after sprints, soreness, and
overall feelings of energy after the sessions were completed.
For the
football athletes, the tests performed consisted of 60 minute weight lifting
sessions. Each athlete was monitored for any potential adverse reaction such as
abnormal change in heart rate, etc. during these tests. The athletes performed
weight lifting routines designed by the strength coaches, and consisted of
exercises such as Bench Press, Dumbell Flys, Shoulder Press, Lat Pulldowns,
etc., with each exercise being performed for 3 sets of 8 repetitions. During the
tests, the athletes were asked to complete a questionnaire, and report - both
objectively and subjectively - what results were obtained while performing the
weight lifting exercises. Information of interest included how much weight the
athlete was able to lift while performing the exercises, how well the athlete
was able to recover between exercises, any muscle cramping, soreness, and
overall feelings of energy after the weight lifting sessions were
completed.
In GROUP (1), the control group for the track and field
athletes, there was no change noted in the athletes performance during the
duration of the two week study. After each 90 minute sprint session, these
athletes reported feeling tired, with most athletes experiencing muscle soreness
after the sessions were completed.
In GROUP (2) the test group for the
track and field athletes that used the LifeWave patches, there was a significant
difference in the athletes performance from the base line study to the test
study. While using the LifeWave patches, all athletes (10/10) reported having
more energy while sprinting, and recovering more quickly between sprints. In
addition, the LifeWave users reported feeling energetic at the end of the sprint
session, with little or no muscle cramping, and no soreness.
In GROUP
(3), the control group for the football athletes, there was no change noted in
the athletes performance during the duration of the two week study. After each
60 minute weight lifting session, these athletes reported feeling fatigued and
sore.
In GROUP (4), the test group for the football athletes that used
the LifeWave patches, there was a significant difference in the athletes
performance from the base line study to the test study. While using the LifeWave
patches, all athletes reported having more energy while weight lifting, as well
as significant improvements in the amount of weight that they were able to lift.
Some representative examples would include: Athlete # 1 performed Dumbell Flys
with 65 lb. dumbells in the base line study for 3 sets of 8 reps, but when using
the LifeWave patches performed Dumbell Flys with 80 lb. dumbells for 3 sets of 8
reps. Athlete # 2 performed a Bench Press with 185 lbs. in the base line study
for 3 sets of 8 reps, but when using the LifeWave patches performed a Bench
Press with 225 lbs. for 3 sets of 8 reps. Athlete # 3 performed a Lat Pulldown
with 90 lbs. in the base line study for 3 sets of 8 reps, but when using the
LifeWave patches performed a Lat Pulldown with 180 lbs. for 3 sets of 8 reps.
APPLICATION
In general, the LifeWave device may
be applied virtually anywhere on the human body for the purpose of promoting a
beneficial response. However, as an interesting note, the most effective
locations appear to coincide with points as described in the system of
acupuncture. Because acupuncture points typically coincide with locations of
high electropotential - as discovered by Walter Rawls - this correlation is not
surprising.
For example, in all of the tests administered as cited, the
LifeWave device was placed along the midline of the epigastric region in the
depression located in the center of the chest. In acupuncture, this point is
referred to "Shanzhong", and is described as being located along the Ren channel
on the anterior midline, at the level of the fourth intercostal space.
Additionally, a second point of interest for the placement of the LifeWave
device would include the midline of the umbilical region; "Zhongji", 4 cun below
the umbilicus, and the crossing point of the Ren channel.
If the two
patch system is utilized (white patch and tan patch), then the white patch is
applied to the right forearm, and the tan patch is applied to the left forearm.
It has been observed that in most individuals the LifeWave effect is more
dramatic and pronounced with the two patch system as opposed to using only one
patch (white only). This may be understood in terms of total surface area of
exposure, as well as electron flow in one localized region as opposed to
electron flow between two distant sites.
A SIMPLE TEST
For individuals who are new to
LifeWave, there are numerous simple and quick tests that may be performed to
demonstrate to the user the validity of the LifeWave technology. As one example,
an individual would first perform an exercise such as push-ups for as many
repetitions as possible (one set only; perform to failure). The user would then
apply the LifeWave patches, wait a few minutes (or to recovery), and then
perform the push-ups for as many repetitions as possible (one set only; to
failure). What most individuals will find is that when wearing the LifeWave
patches it is possible to perform more push-ups than without LifeWave. In fact,
it is typical for users to exceed 25% improvements with this simple test.
CLINICAL STUDIES
All materials
used in the LifeWave patches have been clinically tested for safety and
efficacy. Double Blind placebo controlled studies have been performed for the
purpose of determining the effectiveness of these ingredients on athletic
performance, namely strength and stamina improvements. In tests performed by
LifeWave, over 99% of users experienced improvements in strength and/or stamina
within minutes of using the product. In addition, most individuals who used
LifeWave who suffered from some type of muscular ache or discomfort found relief
within a period of from 2 minutes to 30 minutes. Further, all materials used in
LifeWave products are listed under FDA 21 CFR, and manufactured at FDA
registered facilities.
CONCLUSION
In conclusion, based on
the observed and reported beneficial effects that hundreds of users of the
LifeWave devices have relayed to us, it is clear that a legitimate, beneficial
and efficacious physiological augmentation of the motor unit response and
voluntary muscular system is taking place, with the mode of operation of the
LifeWave device being a new and valuable phenomena. As more data is collected by
both LifeWave Products, LLC and third party laboratories, further insight into
this augmentation phase will be achieved. LifeWave Products, LLC is dedicated to
bringing the consumer only safe and valuable technologies that promote strength,
stamina and wellness. Due to the LifeWave phenomena, the professional athlete,
or any individual who desires increased strength, stamina or pain relief, may
achieve these results within minutes of wearing the LifeWave device technology.
REFERENCES
- Bassett, et. al., Generation of Electric Potentials by Bone in Response
to Mechanical Stress, Science, 1962
- Bassett, et. al., Effects of Electric Currents on Bones in Vivo,
Nature, 1964
- Bassett, et. al., Acceleration of Fracture Repair by Electromagnetic
fields: A Surgically Non-Invasive Method, Ann. NY Acad. Sci., 1974
- Becker, Stimulation of Partial Limb Regeneration in Rats, Nature,
1972
- Black, et. al., Electrode Material and Current Density in Electrical
Stimulation of Osteogenesis, BRAGS, 1982
- Blilie, et. al., Predicting and Validating Cardiothoracic Current Flow
Using Finite Element Modeling, PACE, 1992
- Chapman, Non-Thoracotomy Internal Defibrillation: Improved Efficacy
with Biphasic Shocks, Circulation, 1991
- Duarte, et. al., Endothelium-derived oxidative stress may contribute to
exercise-induced muscle damage, Int J Sports Med, 14: 440-443, 1993
- Feeser, et. al., Strength-Duration and Probability of Success Curves
for Defibrillation with Biphasic Waveforms, Circulation, 82(6), 1990
- Fisher, et. al, Statistical Tables for Biological, Agricultural, and
Medical Research, Hafner Press, 1953
- Guyton, Textbook of Medical Physiology, pp. 98-99, 1991
- Harris, et. al., Acetylcarnitine Formation During Intense Muscular
Contraction in Humans, J Appl Physiol, 63, 1987
- Hicks, Fundamental Concepts in the Design of Experiments, Holt
Rinehart and Winston, 1973
- Hulsmann, et. al., Aspects of Fatty Acid Metabolism in Vascular
Endothelial Cells, Biochimie, 70, 1988
- Jin, et. al., Incomplete Fatty Acid Oxidation, J Biol Chem, 267,
1992
- Kerner and Hoppel, Fatty Acid Import Into Mitochondria, Biochim
Biophys Acta, 1486:1-17, 2000
- Lehninger, How Cells Transform Energy, Sci. Amer., Sept. 1961
- Levy, Induced Osteogenesis by Electrical Stimulation, J. Electrochem
Soc. Electrochemical Science, 1971
- Meites, Biogenic Amines in the Control of Prolactin and Growth Hormone
Secretion, Psychopharm. Bull., Oct. 1976
- Nicholson, A Guide to Metabolic Pathways and Co-enzymes, Grand
Island Biologicals
- Peng, The Design and Analysis of Scientific Experiments, Addison
Wesley, 1967
- Perna, Verapamil Reverses PTH- or CRF-Induced Abnormal Fatty Acid
Oxidation in Muscle, Kidney, Int, 34, 1988
- Stastny, et. al., Epidermal Growth Factor: Induction of Ornithine
Decarboxylase, Biochem. Biophys. Acta, 1970
- Waters, et. al., Treatment of the Hemiplegic Upper Extremity Using
Electrical Stimulation and Biofeedback Training, Report to the Veterans
Administration, Sept., 1980
- Yap, et. al., An Introduction to Dental Electronic Anesthesia,
Quintessence International, V27, No.5, 1996
ABOUT THE
INVENTOR
While conducting undergrad and masters studies at
Pace University during the 1980's, Mr. Schmidt received a grant from a
private corporation in New Jersey for the purpose of investigating new and
alternative therapies for immunogenic and non-immunogenic neuroblastomas.
This work was performed in conjunction with the support of the Children’s
Hospital Of Philadelphia, and resulted in the discovery of a new method for
selectively targeting C1300 and TBJ cancer cells without harming the host’s
cells.
Over the past 15 years, Mr. Schmidt has been a true innovator
in the field of research and development. He has been credited with
inventing such numerous intellectual properties as a biomimetic battery,
organic plastic, novel ultrasonic probe designs, and new fuel cell anodes
amongst others. He has not only developed new and patent pending methods for
the production of Hydrogen gas on demand from water, but has also made
contributions to the integration of these systems with multi-fuel combustion
chambers and bladeless turbine engines.
In addition, Mr. Schmidt is
responsible for pioneering work conducted on behalf of the Navy for new
methods of Oxygen generation. As a result of his innovations, he was invited
to be part of the design team for the Navy’s next generation
submarine.
Amongst his awards, Mr. Schmidt has earned an honorary
doctorate degree from the International Hall Of Fame for accomplishments in
both genetics and metallurgy; he is also a former Board Of Directors member
for NuPro Innovations, Inc., a publicly traded firm engaged in the sale of a
proprietary metaphoric polymer.
At this time, Mr. Schmidt
serves as President of LifeWave Products, LLC. He is the principal
investigator and inventor of the LifeWave technology.
|